{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T05:59:51Z","timestamp":1784527191456,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,16]],"date-time":"2014-08-16T00:00:00Z","timestamp":1408147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s11011-014-9604-6","type":"journal-article","created":{"date-parts":[[2014,8,15]],"date-time":"2014-08-15T02:41:10Z","timestamp":1408070470000},"page":"205-213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["The neuroprotective potential of sinapic acid in the 6-hydroxydopamine-induced hemi-parkinsonian rat"],"prefix":"10.1007","volume":"30","author":[{"given":"Kobra","family":"Zare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Eidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Roghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Haeri","family":"Rohani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,16]]},"reference":[{"key":"9604_CR1","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1046\/j.1460-9568.2000.00181.x","volume":"12","author":"G Andringa","year":"2000","unstructured":"Andringa G, van Oosten RV, Unger W, Hafmans TG, Veening J, Stoof JC, Cools AR (2000) Systemic administration of the propargylamine CGP 3466B prevents behavioural and morphological deficits in rats with 6-hydroxydopamine-induced lesions in the substantia nigra. Eur J Neurosci 12:3033\u20133043","journal-title":"Eur J Neurosci"},{"key":"9604_CR2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbr.2011.06.007","volume":"224","author":"T Baluchnejadmojarad","year":"2011","unstructured":"Baluchnejadmojarad T, Roghani M (2011) Chronic epigallocatechin-3-gallate ameliorates learning and memory deficits in diabetic rats via modulation of nitric oxide and oxidative stress. Behav Brain Res 224:305\u2013310","journal-title":"Behav Brain Res"},{"key":"9604_CR3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neulet.2010.06.038","volume":"480","author":"T Baluchnejadmojarad","year":"2010","unstructured":"Baluchnejadmojarad T, Roghani M, Mafakheri M (2010) Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress. Neurosci Lett 480:206\u2013210","journal-title":"Neurosci Lett"},{"key":"9604_CR4","first-page":"1605","volume":"9","author":"P Bargiotas","year":"2013","unstructured":"Bargiotas P, Konitsiotis S (2013) Levodopa-induced dyskinesias in Parkinson\u2019s disease: emerging treatments. Neuropsychiatr Dis Treat 9:1605\u20131617","journal-title":"Neuropsychiatr Dis Treat"},{"key":"9604_CR5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.arr.2013.12.009","volume":"13C","author":"M Bisaglia","year":"2014","unstructured":"Bisaglia M, Filograna R, Beltramini M, Bubacco L (2014) Are dopamine derivatives implicated in the pathogenesis of Parkinson\u2019s disease? Ageing Res Rev 13C:107\u2013114","journal-title":"Ageing Res Rev"},{"key":"9604_CR6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254","journal-title":"Anal Biochem"},{"key":"9604_CR7","doi-asserted-by":"crossref","first-page":"23103","DOI":"10.3390\/ijms141123103","volume":"14","author":"S Chakraborty","year":"2013","unstructured":"Chakraborty S, Bornhorst J, Nguyen TT, Aschner M (2013) Oxidative stress mechanisms underlying Parkinson\u2019s disease-associated neurodegeneration in C. elegans. Int J Mol Sci 14:23103\u201323128","journal-title":"Int J Mol Sci"},{"key":"9604_CR8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/01.mjt.0000174353.28012.a7","volume":"13","author":"S Chen","year":"2006","unstructured":"Chen S, Le W (2006) Neuroprotective therapy in Parkinson disease. Am J Ther 13:445\u2013457","journal-title":"Am J Ther"},{"key":"9604_CR9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/07315724.2007.10719621","volume":"26","author":"KP Datla","year":"2007","unstructured":"Datla KP, Zbarsky V, Rai D, Parkar S, Osakabe N, Aruoma OI, Dexter DT (2007) Short-term supplementation with plant extracts rich in flavonoids protect nigrostriatal dopaminergic neurons in a rat model of Parkinson\u2019s disease. J Am Coll Nutr 26:341\u2013349","journal-title":"J Am Coll Nutr"},{"key":"9604_CR10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/00207454.2010.535934","volume":"121","author":"DP Araujo De","year":"2011","unstructured":"De Araujo DP, Lobato Rde F, Cavalcanti JR, Sampaio LR, Araujo PV, Silva MC, Neves KR, Fonteles MM, Sousa FC, Vasconcelos SM (2011) The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson\u2019s disease: a review. Int J Neurosci 121:51\u201357","journal-title":"Int J Neurosci"},{"key":"9604_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb07458.x","volume":"991","author":"S Fahn","year":"2003","unstructured":"Fahn S (2003) Description of Parkinson\u2019s disease as a clinical syndrome. Ann N Y Acad Sci 991:1\u201314","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 2","key":"9604_CR12","first-page":"II82","volume":"247","author":"P Foley","year":"2000","unstructured":"Foley P, Riederer P (2000) Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson\u2019s disease. J Neurol 247(Suppl 2):II82\u201394","journal-title":"J Neurol"},{"key":"9604_CR13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1749-6632.2009.05118.x","volume":"1184","author":"GM Halliday","year":"2010","unstructured":"Halliday GM, McCann H (2010) The progression of pathology in Parkinson\u2019s disease. Ann N Y Acad Sci 1184:188\u2013195","journal-title":"Ann N Y Acad Sci"},{"key":"9604_CR14","first-page":"241","volume":"44","author":"N Hattori","year":"2004","unstructured":"Hattori N (2004) Etiology and pathogenesis of Parkinson\u2019s disease: from mitochondrial dysfunctions to familial Parkinson\u2019s disease. Rinsho Shinkeigaku 44:241\u2013262","journal-title":"Rinsho Shinkeigaku"},{"key":"9604_CR15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainres.2013.01.054","volume":"1505","author":"M Jalali-Nadoushan","year":"2013","unstructured":"Jalali-Nadoushan M, Roghani M (2013) Alpha-lipoic acid protects against 6-hydroxydopamine-induced neurotoxicity in a rat model of hemi-parkinsonism. Brain Res 1505:68\u201374","journal-title":"Brain Res"},{"issue":"Suppl 1","key":"9604_CR16","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1016\/S1353-8020(13)70038-5","volume":"20","author":"W Le","year":"2014","unstructured":"Le W (2014) Role of iron in UPS impairment model of Parkinson\u2019s disease. Parkinsonism Relat Disord 20(Suppl 1):S158\u2013161","journal-title":"Parkinsonism Relat Disord"},{"key":"9604_CR17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pbb.2012.08.015","volume":"103","author":"HE Lee","year":"2012","unstructured":"Lee HE, Kim DH, Park SJ, Kim JM, Lee YW, Jung JM, Lee CH, Hong JG, Liu X, Cai M, Park KJ, Jang DS, Ryu JH (2012) Neuroprotective effect of sinapic acid in a mouse model of amyloid beta (1\u201342) protein-induced Alzheimer\u2019s disease. Pharmacol Biochem Behav 103:260\u2013266","journal-title":"Pharmacol Biochem Behav"},{"key":"9604_CR18","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn983","volume":"3","author":"J Lotharius","year":"2002","unstructured":"Lotharius J, Brundin P (2002) Pathogenesis of Parkinson\u2019s disease: dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci 3:932\u2013942","journal-title":"Nat Rev Neurosci"},{"key":"9604_CR19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cbi.2011.08.004","volume":"194","author":"L Pari","year":"2011","unstructured":"Pari L, Mohamed Jalaludeen A (2011) Protective role of sinapic acid against arsenic: induced toxicity in rats. Chem Biol Interact 194:40\u201347","journal-title":"Chem Biol Interact"},{"key":"9604_CR20","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"1986","unstructured":"Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic, San Diego","edition":"2"},{"key":"9604_CR21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3382\/ps.2007-00357","volume":"87","author":"HY Qiao","year":"2008","unstructured":"Qiao HY, Dahiya JP, Classen HL (2008) Nutritional and physiological effects of dietary sinapic acid (4-hydroxy-3,5-dimethoxy-cinnamic acid) in broiler chickens and its metabolism in the digestive tract. Poult Sci 87:719\u2013726","journal-title":"Poult Sci"},{"key":"9604_CR22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.brainresbull.2010.06.004","volume":"82","author":"M Roghani","year":"2010","unstructured":"Roghani M, Niknam A, Jalali-Nadoushan MR, Kiasalari Z, Khalili M, Baluchnejadmojarad T (2010) Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism. Brain Res Bull 82:279\u2013283","journal-title":"Brain Res Bull"},{"key":"9604_CR23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejphar.2012.11.012","volume":"699","author":"SJ Roy","year":"2013","unstructured":"Roy SJ, Mainzen Prince PS (2013) Protective effects of sinapic acid on cardiac hypertrophy, dyslipidaemia and altered electrocardiogram in isoproterenol-induced myocardial infarcted rats. Eur J Pharmacol 699:213\u2013218","journal-title":"Eur J Pharmacol"},{"key":"9604_CR24","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1016\/j.fct.2012.08.017","volume":"50","author":"SJ Roy","year":"2012","unstructured":"Roy SJ, Stanely Mainzen Prince P (2012) Protective effects of sinapic acid on lysosomal dysfunction in isoproterenol induced myocardial infarcted rats. Food Chem Toxicol 50:3984\u20133989","journal-title":"Food Chem Toxicol"},{"key":"9604_CR25","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/mds.23732","volume":"26","author":"AH Schapira","year":"2011","unstructured":"Schapira AH, Jenner P (2011) Etiology and pathogenesis of Parkinson\u2019s disease. Mov Disord 26:1049\u20131055","journal-title":"Mov Disord"},{"key":"9604_CR26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","volume":"318","author":"A Schober","year":"2004","unstructured":"Schober A (2004) Classic toxin-induced animal models of Parkinson\u2019s disease: 6-OHDA and MPTP. Cell Tissue Res 318:215\u2013224","journal-title":"Cell Tissue Res"},{"key":"9604_CR27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0006-8993(87)90885-7","volume":"426","author":"RM Shapiro","year":"1987","unstructured":"Shapiro RM, Glick SD, Camarota NA (1987) A two-population model of rat rotational behavior: effects of unilateral nigrostriatal 6-hydroxydopamine on striatal neurochemistry and amphetamine-induced rotation. Brain Res 426:323\u2013331","journal-title":"Brain Res"},{"key":"9604_CR28","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s12272-013-0050-5","volume":"36","author":"DS Shin","year":"2013","unstructured":"Shin DS, Kim KW, Chung HY, Yoon S, Moon JO (2013) Effect of sinapic acid against carbon tetrachloride-induced acute hepatic injury in rats. Arch Pharm Res 36:626\u2013633","journal-title":"Arch Pharm Res"},{"key":"9604_CR29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/npp.2011.212","volume":"37","author":"Y Smith","year":"2012","unstructured":"Smith Y, Wichmann T, Factor SA, DeLong MR (2012) Parkinson\u2019s disease therapeutics: new developments and challenges since the introduction of levodopa. Neuropsychopharmacology 37:213\u2013246","journal-title":"Neuropsychopharmacology"},{"key":"9604_CR30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11481-007-9070-6","volume":"2","author":"K Sriram","year":"2007","unstructured":"Sriram K, O\u2019Callaghan JP (2007) Divergent roles for tumor necrosis factor-alpha in the brain. J Neuroimmune Pharmacol 2:140\u2013153","journal-title":"J Neuroimmune Pharmacol"},{"key":"9604_CR31","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.neurobiolaging.2013.10.077","volume":"35","author":"V Tapias","year":"2013","unstructured":"Tapias V, Cannon JR, Greenamyre JT (2013) Pomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson\u2019s disease. Neurobiol Aging 35:1162\u20131176","journal-title":"Neurobiol Aging"},{"key":"9604_CR32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pneurobio.2004.05.002","volume":"73","author":"O Bohlen und Halbach Von","year":"2004","unstructured":"Von Bohlen und Halbach O, Schober A, Krieglstein K (2004) Genes, proteins, and neurotoxins involved in Parkinson\u2019s disease. Prog Neurobiol 73:151\u2013177","journal-title":"Prog Neurobiol"},{"key":"9604_CR33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12031-011-9693-1","volume":"47","author":"J Wang","year":"2012","unstructured":"Wang J, Xu H, Jiang H, Du X, Sun P, Xie J (2012) Neurorescue effect of rosmarinic acid on 6-hydroxydopamine-lesioned nigral dopamine neurons in rat model of Parkinson\u2019s disease. J Mol Neurosci 47:113\u2013119","journal-title":"J Mol Neurosci"},{"key":"9604_CR34","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.freeradbiomed.2013.01.017","volume":"62","author":"O Weinreb","year":"2013","unstructured":"Weinreb O, Mandel S, Youdim MB, Amit T (2013) Targeting dysregulation of brain iron homeostasis in Parkinson\u2019s disease by iron chelators. Free Radic Biol Med 62:52\u201364","journal-title":"Free Radic Biol Med"},{"key":"9604_CR35","doi-asserted-by":"crossref","first-page":"10265","DOI":"10.1021\/jf802095g","volume":"56","author":"KJ Yun","year":"2008","unstructured":"Yun KJ, Koh DJ, Kim SH, Park SJ, Ryu JH, Kim DG, Lee JY, Lee KT (2008) Anti-inflammatory effects of sinapic acid through the suppression of inducible nitric oxide synthase, cyclooxygase-2, and proinflammatory cytokines expressions via nuclear factor-kappaB inactivation. J Agric Food Chem 56:10265\u201310272","journal-title":"J Agric Food Chem"},{"key":"9604_CR36","first-page":"220","volume":"68C","author":"ZD Zhou","year":"2013","unstructured":"Zhou ZD, Refai FS, Xie SP, Ng SH, Chan CH, Ho PG, Zhang XD, Lim TM, Tan EK (2013) Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neurons. Free Radic Biol Med 68C:220\u2013233","journal-title":"Free Radic Biol Med"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-014-9604-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-014-9604-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-014-9604-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T22:22:04Z","timestamp":1559341324000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-014-9604-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,16]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["9604"],"URL":"https:\/\/doi.org\/10.1007\/s11011-014-9604-6","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,16]]}}}